multiple myeloma

September 7, 2015September 9, 2015

FDA Accepts Bristol-Myers Squibb’s and AbbVie’s Empliciti for Multiple Myeloma BLA for Priority Review

News

The US Food and Drug Administration has accepted Bristol-Myers Squibb Company’s and AbbVie’s joint Biologics License Application (BLA) for Empliciti’s (elotuzumab) priority review. Empliciti is an experimental Signaling Lymphocyte Activation Molecule (SLAMF7)-directed immunostimulatory antibody, for the ... Read more

September 2, 2015September 4, 2015

Dasatinib May Improve Remission in Lymphoma Patients Following Stem Cell Transplant

News

Autologous stem cell transplantation (SCT) is one treatment procedure for multiple myeloma, non-Hodgkin lymphoma, and Hodgkin lymphoma that has shown clinical success. However, there is room for improvement in the ... Read more

July 17, 2015July 17, 2015

Genetic Research Can Improve Blood Cancer Treatments for African Americans

News

Genetic research has steadily been gaining popularity in the field of biomedical research, as scientists have seen how understanding a patient’s genetic makeup can ultimately help them create personalized treatment – ones that ... Read more